Sana Biotechnology Inc (SANA) — Cash Flow-to-Debt Ratio
Sana Biotechnology Inc (SANA) has a Cash Flow-to-Debt Ratio of -0.12x as of June 2026, meaning its operating cash flow of $-32.79 Million could theoretically repay 0% of its total liabilities ($276.95 Million) in one year. See Sana Biotechnology Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sana Biotechnology Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Sana Biotechnology Inc across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Sana Biotechnology Inc generate cash.
Annual Cash Flow-to-Debt Ratio for Sana Biotechnology Inc (2018–2025)
Year-by-year debt coverage analysis for Sana Biotechnology Inc. Check how high is Sana Biotechnology Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.56x | $-143.83 Million | $256.01 Million | ▲ +36.9% |
| 2024 | -0.89x | $-223.15 Million | $250.52 Million | ▲ +2.4% |
| 2023 | -0.91x | $-253.58 Million | $277.79 Million | ▼ -1.8% |
| 2022 | -0.90x | $-290.05 Million | $323.40 Million | ▼ -43.2% |
| 2021 | -0.63x | $-251.05 Million | $400.90 Million | ▼ -422.6% |
| 2020 | -0.12x | $-137.98 Million | $1.15 Billion | ▲ +21.8% |
| 2019 | -0.15x | $-85.50 Million | $557.73 Million | ▲ +46.0% |
| 2018 | -0.28x | $-13.49 Million | $47.52 Million | — |